ISSAR Pharma

Featured Article

Psoriasis patients undergoing biologic/other systemic therapies may experience mild SARS-CoV-2 infection

Psoriasis patients undergoing biologic/other systemic therapies may experience mild SARS-CoV-2 infection A recent study published in the ‘Medicina’ Journal by the Multidisciplinary …

CXCL9: A biomarker for Vitiligo activity

CXCL9: A biomarker for Vitiligo activity A recent study published in the ‘Nature’ scientific journal, proposed that the CXCL9 gene is a …

Untitled design(4)

Rheumatoid Arthritis (RA) In a Global Burden of Disease (GBD) study conducted in the year 2010, which studied 291 conditions, Rheumatoid Arthritis …

unique-young-woman-with-vitiligo-skin

The global prevalence rate of vitiligo ranges between 0.4%-3%, affecting individuals of all ages, races, and genders. Vitiligo treatment market dynamics Combination …

The illustration of stomach and large intestine is on the woman's body against gray background. Acid reflux. Female anatomy

Inflammatory Bowel Diseases (IBD) currently affect approximately 0.5% of the Western world’s population. The globally occurring cases increased from 3.7 million to over …

psoriasis-skin-closeup-rash-scaling-patient-s-skin(1)

The global prevalence of psoriasis ranges between 0.09% to 11.14 %. Psoriasis affects >120 million worldwide, with no cure till date. The …